Skip to content
Immigration, Medical Health Aged Care

Aged care workforce shortages to be examined by the Migration Committee

Parliament of Australia 2 mins read

Workforce shortages in the aged care sector and the role migration can play in helping to ease them will take centre stage at the final public hearing of the Joint Standing Committee on Migration’s Migration, Pathway to Nation Building inquiry tomorrow.

Committee Chair, Maria Vamvakinou MP, said ‘Australia is an ageing society experiencing ever-increasing demands on its aged care sector. The committee has received evidence that the aged care sector is facing acute workforce shortages in meeting these demands—a shortfall measured in the tens of thousands of workers over the coming years.

‘While we must train more Australians to fill these roles, this takes time and may not fully meet the labour demands of the sector. Migration must play a role in providing skilled and compassionate workers to care for our parents and grandparents in their old age’.       

The committee will hear from aged care providers, industry peak bodies, specialists in migration law and the aged care sector, and Australia’s largest skills assessment provider, VETASSESS, who will discuss a recent project they have been involved in for the provision of skilled aged care workers from overseas.

‘The committee is interested to hear directly from industry insiders on the workforce challenges the sector is experiencing and how they think migration can help alleviate these’, Ms Vamvakinou said.

Additionally, in-line with another key focus area of the inquiry—migration into regional Australia—the committee will speak with a regional development body and a regional small business on the challenges and opportunities they face in bringing migrants into the regions. 

The committee will also hear from the Office of the Migration Agents Registration Authority (OMARA) and their regulatory role in both protecting migrants who require immigration advice and in ensuring the integrity of the migration advice industry.

Lastly, the committee will hear evidence from an international education services and language testing provider on the role of language testing and the experience of international students in our migration system and from a refugee advocate on the experiences of those coming via the humanitarian program.

The full hearing program is available on the Committee’s website.

Hearing details

Wednesday, 27 September 2023 – 9am to 4.40pm – Videoconference

Media inquiries

Committee Chair
02 6277 4249
Maria.Vamvakinou.MP@aph.gov.au

For background information

Committee Secretariat
02 6277 4560
migration@aph.gov.au

For more information about this committee, you can visit its website. On the website you can track the committee and receive email updates by clicking on the blue ‘Track this Committee’ button in the bottom right hand corner of the page.

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.